Percutaneous Mitral Valve Anchoring via Clamp Jaws

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current prosthetic mitral valve replacement procedures face challenges due to the unique anatomy of the mitral valve, including complex geometry, lack of calcification, and the presence of chordae tendineae, leading to difficulties in anchoring and navigating deployment catheters, resulting in high rejection rates and the need for improved, less invasive treatment options.

Innovation Solution

A percutaneous prosthetic mitral valve system with a stent design featuring atrial and ventricular clamp jaws that are resiliently biased to grip the native mitral valve annulus and leaflets, allowing for secure anchoring and adjustment using suture loops, and can be delivered via catheters through veins or arteries, accommodating the complex anatomy of the mitral valve area.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If percutaneous mitral valve replacement is attempted using expandable stent prostheses, then less invasive treatment is achieved, but the lack of calcification and radial support in the mitral valve anatomy makes anchoring difficult and may lead to collapse of adjacent structures

Engineering Contradiction:
Improveinvasiveness of procedureVSAvoidanchoring reliability
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The prosthetic valve system is divided into multiple functional components: an expandable frame structure, anchoring mechanisms (such as apical anchors or annular engagement elements), and a valve component. This segmentation allows each component to perform its specific function - the frame provides structural support, the anchors provide secure fixation to the mitral annulus or adjacent structures, and the valve component ensures proper function, thereby resolving the anchoring reliability issue while maintaining percutaneous access

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The valve component is nested within the expandable frame structure, which itself is designed to engage with the mitral annulus or adjacent cardiac structures. This nested configuration allows the entire assembly to be delivered through a catheter in a compressed state and then deployed in situ, achieving both minimally invasive delivery and reliable anchoring through the hierarchical structural arrangement

Inventive Principle:
Principle #7Nested doll (Nesting)

2Reliability

If surgical repair or replacement procedures are used, then reliable valve replacement is achieved, but the procedures are highly invasive and not feasible for high-risk patients

Engineering Contradiction:
Improvevalve replacement reliabilityVSAvoidinvasiveness of procedure
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

An expandable frame structure with integrated anchoring mechanisms serves as an intermediary between the percutaneous delivery system and the native mitral valve. This intermediary structure provides the necessary mechanical support and secure fixation that would otherwise require open surgical intervention, while still allowing for minimally invasive catheter-based delivery in high-risk patients

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If the mitral valve anatomy is accommodated with robust anchoring systems, then anchoring reliability is improved, but the risk of collapsing the inferior portion of the aortic tract increases

Engineering Contradiction:
Improveanchoring reliabilityVSAvoidrisk to adjacent structures
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The anchoring forces are localized to specific regions of the mitral annulus or adjacent structures through targeted engagement elements, rather than applying diffuse radial forces across the entire annulus. This localized anchoring approach provides secure fixation while minimizing the risk of collapsing the inferior portion of the aortic tract or damaging other adjacent cardiac structures

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The expandable frame structure is designed with predetermined engagement characteristics that allow it to securely anchor to the mitral annulus or adjacent structures upon deployment. The frame's expansion geometry and anchoring element configuration are pre-engineered to achieve reliable fixation while controlling the distribution of forces to protect adjacent structures from collapse or damage

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system enables reliable, less invasive percutaneous replacement of mitral valves with improved anchoring and positioning, reducing rejection rates and facilitating treatment of mitral valve disease, including conditions like regurgitation and stenosis, while minimizing risk to surrounding structures.

Implementation Method 1

atrial and ventricular clamp jaws that are resiliently biased to grip the native mitral valve annulus and leaflets

Methodology Applied
Scientific EffectElasticity: Elasticity

Data Source

PatentUS20230078372A1Prosthetic Atrio-Ventricular Valve Systems and Devices
Publication Date: 2023.03.16 LAGUNA TECH USA INC
  • US20230078372A1 patent drawing
  • US20230078372A1 patent drawing
  • US20230078372A1 patent drawing

AI summary

A prosthetic mitral valve system that comprises a valve dock and a prosthetic mitral valve is disclosed. The valve dock comprises clamp jaws that sandwich the native mitral valve leaflets and the native mitral valve annulus between them anchoring the prosthetic mitral valve system at or adjacent to the native mitral valve annulus. Further, a prosthetic mitral valve comprising atrial and ventricular clamp jaws and which can be implanted at or adjacent to the native mitral valve annulus without a valve dock system is disclosed. Novel methods and systems for treating mitral valve disease or malfunction by percutaneous replacement of the mitral valve (or the tricuspid valve) are disclosed.